Kymera Therapeutics Correlations

KYMR Stock

USD 40.61 0.32 0.79%

The current 90-days correlation between Kymera Therapeutics and Foghorn Therapeutics is 0.63 (i.e., Poor diversification). The correlation of Kymera Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Kymera Therapeutics Correlation With Market

Modest diversification

The correlation between Kymera Therapeutics and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kymera Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

To learn how to invest in Kymera Stock, please use our How to Invest in Kymera Therapeutics guide.

Moving together with Kymera Stock

0.61	ME	23Andme Holding	Pair Corr
0.92	DNLI	Denali Therapeutics	Pair Corr
0.71	DNTH	Dianthus Therapeutics	Pair Corr
0.81	DOMH	Dominari Holdings	Pair Corr
0.74	DRRX	Durect	Pair Corr
0.83	DTIL	Precision BioSciences	Pair Corr
0.82	VIGL	Vigil Neuroscience	Pair Corr
0.73	VINC	Vincerx Pharma	Pair Corr
0.84	VKTX	Viking Therapeutics	Pair Corr
0.66	VRCA	Verrica Pharmaceuticals	Pair Corr
0.81	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.71	VRPX	Virpax Pharmaceuticals	Pair Corr
0.86	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Kymera Stock

0.73	DRTS	Alpha Tau Medical	Pair Corr
0.73	CDIOW	Cardio Diagnostics	Pair Corr
0.58	DMAC	DiaMedica Therapeutics	Pair Corr
0.52	VCEL	Vericel Corp Ord	Pair Corr
0.52	SABSW	SAB Biotherapeutics	Pair Corr
0.49	VCYT	Veracyte Potential Growth	Pair Corr
0.73	SRZNW	Surrozen Warrant	Pair Corr
0.7	VRNA	Verona Pharma PLC	Pair Corr
0.67	DYAI	Dyadic International	Pair Corr
0.45	VSTM	Verastem	Pair Corr
0.38	KTTAW	Pasithea Therapeutics	Pair Corr

Related Correlations Analysis

	FHTX	STTK	GLUE	NRIX	RVMD	CCCC	AGIO	IPSC	EWTX	MLYS
FHTX		0.22	0.47	0.88	0.89	0.72	0.82	0.76	0.89	0.68	FHTX
STTK	0.22		-0.25	0.43	-0.05	0.57	-0.08	0.36	0.25	0.43	STTK
GLUE	0.47	-0.25		0.19	0.59	-0.04	0.66	0.32	0.29	0.32	GLUE
NRIX	0.88	0.43	0.19		0.69	0.89	0.54	0.64	0.88	0.68	NRIX
RVMD	0.89	-0.05	0.59	0.69		0.46	0.82	0.57	0.7	0.53	RVMD
CCCC	0.72	0.57	-0.04	0.89	0.46		0.29	0.65	0.82	0.71	CCCC
AGIO	0.82	-0.08	0.66	0.54	0.82	0.29		0.72	0.65	0.43	AGIO
IPSC	0.76	0.36	0.32	0.64	0.57	0.65	0.72		0.74	0.71	IPSC
EWTX	0.89	0.25	0.29	0.88	0.7	0.82	0.65	0.74		0.75	EWTX
MLYS	0.68	0.43	0.32	0.68	0.53	0.71	0.43	0.71	0.75		MLYS
	FHTX	STTK	GLUE	NRIX	RVMD	CCCC	AGIO	IPSC	EWTX	MLYS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RVMD	+ 0.89	FHTX
EWTX	+ 0.89	FHTX
CCCC	+ 0.89	NRIX
NRIX	+ 0.88	FHTX
EWTX	+ 0.88	NRIX
AGIO	+ 0.82	FHTX

High negative correlations

GLUE	- 0.25	STTK
AGIO	- 0.08	STTK
RVMD	- 0.05	STTK
CCCC	- 0.04	GLUE

Risk-Adjusted Indicators

There is a big difference between Kymera Stock performing well and Kymera Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Kymera Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
FHTX	3.27	(0.77)	0.00	(0.53)	0.00	0.00	5.05	(8.30)	20.44
STTK	4.17	(0.38)	0.00	1.02	0.00	0.00	10.62	(9.01)	22.78
GLUE	5.64	0.75	0.15	2.00	4.70	(8.18)	10.21	(8.46)	103.72
NRIX	2.77	(0.37)	0.00	(0.42)	0.00	0.00	6.17	(4.73)	20.84
RVMD	2.07	(0.28)	0.00	(0.51)	0.00	0.00	4.11	(5.94)	16.40
CCCC	4.32	(0.50)	0.00	(0.26)	0.00	0.00	9.28	(8.28)	24.60
AGIO	3.06	(0.28)	0.00	(0.33)	0.00	0.00	6.76	(7.01)	31.56
IPSC	3.92	(0.63)	0.00	(0.67)	0.00	0.00	6.73	(7.48)	31.00
EWTX	2.71	(0.26)	0.00	(0.13)	0.00	0.00	4.89	(5.54)	26.07
MLYS	3.37	(0.49)	0.00	(1.25)	0.00	0.00	7.79	(6.95)	26.52

Kymera Therapeutics Corporate Management

Jared MD	Chief Officer	Profile
DPhil DPHIL	CoFounder Chairman	Profile
JD Esq	Chief Secretary	Profile
Karen Weisbach	Head Culture	Profile
Juliet BA	Head Research	Profile
Melissa Brody	VP Devel	Profile
Elaine Caughey	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC